Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Varian Medical Systems Inc (VAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013183
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linear accelerators, treatment simulation and verification equipment, X-ray tubes, high voltage connectors, and flat panel digital image detectors. Varian also offers software solutions for information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support and practice management. The company’s products find application in fluoroscopic imaging, mammography, computed tomography, cargo scanning, computer-aided diagnostics and other industrial applications. Varian offers its products to healthcare agencies, physicians’ offices, university research and community hospitals, and private and governmental institutions. The company has presence in North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US.

Varian Medical Systems Inc (VAR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Varian Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Varian Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 10
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Varian Medical Systems Completes Acquisition Of Certain Assets From Velocity Medical Solutions 12
Venture Financing 14
Fusion Pharma Raises Additional USD17 Million in Series A Financing 14
Grail Raises USD914 Million in First Tranche of Series B Financing 16
Partnerships 18
DNAmito Enters into Development Agreement with Varian Medical Systems 18
Cancer Research UK Enters Into Co-Development Agreement With Centella Therapeutics And Cancer Research Technology 19
Licensing Agreements 20
Centella Therapeutics Enters Into Licensing Agreement With Auckland UniServices For CEN-209 20
Acquisition 21
Varian Medical Systems to Acquire Claymount Assemblies 21
Varian Medical Systems Acquires Majority Stake in MeVis Medical Solutions for USD37.4 Million in Tender Offer 22
Varian Medical Systems Inc – Key Competitors 24
Varian Medical Systems Inc – Key Employees 25
Varian Medical Systems Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
Apr 04, 2017: Varian Medical Systems Establishes Direct Operation in South Africa 30
Jan 30, 2017: Varian Announces Successful Separation of Imaging Components Business 31
Mar 03, 2016: Varian Medical Systems Breaks Ground On New Brazil Facility 32
Financial Announcements 33
Jul 26, 2017: Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital 33
Apr 26, 2017: Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 34
Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017 35
Oct 26, 2016: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016 37
Jul 27, 2016: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016 39
Apr 27, 2016: Varian Medical Systems Reports Results For Second Quarter Of Fiscal Year 2016 40
Jan 27, 2016: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2016 41
Corporate Communications 42
Apr 05, 2017: Varian Medical Systems Names New CFO 42
Mar 01, 2017: José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems 43
Oct 26, 2016: Elisha W. Finney Announces Plan to Retire as CFO of Varian Medical Systems 44
Aug 22, 2016: Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board 45
Mar 07, 2016: Varian Medical Systems Announces Particle Therapy Scientific Advisory Board 46
Legal and Regulatory 47
Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 47
Other Significant Developments 48
Jul 21, 2016: Varian Medical Systems Announces Company Name For Imaging Components Business 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Varian Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Varian Medical Systems Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Varian Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 10
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Varian Medical Systems Completes Acquisition Of Certain Assets From Velocity Medical Solutions 12
Fusion Pharma Raises Additional USD17 Million in Series A Financing 14
Grail Raises USD914 Million in First Tranche of Series B Financing 16
DNAmito Enters into Development Agreement with Varian Medical Systems 18
Cancer Research UK Enters Into Co-Development Agreement With Centella Therapeutics And Cancer Research Technology 19
Centella Therapeutics Enters Into Licensing Agreement With Auckland UniServices For CEN-209 20
Varian Medical Systems to Acquire Claymount Assemblies 21
Varian Medical Systems Acquires Majority Stake in MeVis Medical Solutions for USD37.4 Million in Tender Offer 22
Varian Medical Systems Inc, Key Competitors 24
Varian Medical Systems Inc, Key Employees 25
Varian Medical Systems Inc, Subsidiaries 27
Varian Medical Systems Inc, Joint Venture 29

★海外企業調査レポート[Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Canada Pension Plan Investment Board:戦略・SWOT・企業財務分析
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Multiple Myeloma Research Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Multiple Myeloma Research Foundation Inc (MMRF) is a non-profit foundation that develops advanced multiple myeloma treatments. The foundation provides end-to-end solutions for drug discovery and development targeting multiple myeloma. It provides clinical trails such as molecularly targeted …
  • HEG Ltd (HEG):企業の財務・戦略的SWOT分析
    HEG Ltd (HEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Alios BioPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alios BioPharma Inc (Alios BioPharma), a subsidiary of Janssen Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel therapies for treatment of viral diseases. The company offers drugs for the treatment of viral infections such as respiratory syncytial virus, i …
  • Shiseido Company, Limited:戦略・SWOT・企業財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Baoding Lightway Green Energy Technology Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Baoding Lightway Green Energy Technology Co Ltd (Lightway Green), a subsidiary of LONGJITAIHE Group, is a vertically integrated solar module manufacturer. It specializes in the manufacture of high quality solar PV products, provides professional solutions and customer service. The company de …
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Apollo Endosurgery Inc (APEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System …
  • Altin Yunus Cesme Turistik Tesisler A.S.
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Taiyo Nippon Sanso Corp (4091):企業の財務・戦略的SWOT分析
    Taiyo Nippon Sanso Corp (4091) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Xcel Energy Inc (XEL):電力:M&Aディール及び事業提携情報
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Reno de Medici S.p.A.:企業の戦略・SWOT・財務情報
    Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • OZ Minerals Ltd:企業の戦略・SWOT・財務情報
    OZ Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary OZ Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Westar Energy Inc (WR)-エネルギー分野:企業M&A・提携分析
    Summary Westar Energy, Inc. (Westar Energy) is a vertically integrated energy utility that generates, transmits and distributes electricity. The company owns and operates a generation portfolio of coal-fired, nuclear, natural gas-based, renewable and diesel-based power plants. It also procures elect …
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Aker ASA (AKER):企業の財務・戦略的SWOT分析
    Aker ASA (AKER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Clarion Co Ltd:企業の戦略的SWOT分析
    Clarion Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆